Abstract
Invariant Natural Killer T-cells (iNKT-cells) are an attractive target for immune response modulation, as upon CD1d-mediated stimulation with KRN7000, a synthetic α-galactosylceramide, they produce a vast amount of cytokines. Here we present a synthesis that allows swift modification of the phytosphingosine side chain by amidation of an advanced methyl ester precursor. The resulting KRN7000 derivatives, termed α-galactosylsphingamides, were evaluated for their capacity to stimulate iNKT-cells. While introduction of the amide-motif in the phytosphingosine chain is tolerated for CD1d binding and TCR recognition, the studied α-galactosylsphingamides showed compromised antigenic properties.
Highlights
Invariant natural killer T-cells are a small set of glycolipid reactive T-cells that bridge innate and adaptive immunity
As shown in the retrosynthetic analysis (Fig. 3), the α-galactosylsphingamides (5a-h, 6–9d and 9f) can be accessed from methyl ester 10, which is obtained through Lewis acid catalyzed glycosylation of glycosyl acceptor 12
A series of α-GalCer analogues featuring an amide bond in the phytosphingosine were synthesized
Summary
Invariant natural killer T-cells (iNKT-cells) are a small set of glycolipid reactive T-cells that bridge innate and adaptive immunity They display characteristics of both the NK cell lineage (mouse NK1.1, human CD161) and conventional thymus-derived T-cells[1]. A common strategy for the synthesis of α-GalCer analogues modified in the phytosphingosine moiety relies on the Wittig olefination on L-Garner’s aldehyde, followed by stereoselective dihydroxylation of the Z-double bond furnishing the required d-ribo stereochemistry[14, 22]. This approach may afford high stereoselectivity, it inevitably leads to minor unwanted isomers thereby lowering the overall yield and forcing demanding purification steps ahead in the synthesis
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have